Research programme: antioxidants - CeNeS

Drug Profile

Research programme: antioxidants - CeNeS

Alternative Names: Antioxidants research programme - CeNeS

Latest Information Update: 12 Sep 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CeNeS Pharmaceuticals
  • Class
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 12 Sep 2002 CeNeS has stopped its research activities and is concentrating on development of late stage candidates
  • 12 Sep 2002 Discontinued-preclinical for Alzheimer's disease in United Kingdom (unknown route)
  • 02 Oct 2001 This programme is still being actively researched
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top